Evidence map›Paper›PMID 41089695›Full record

ArticleFrontiers in immunology2025

Folate receptor β performs an immune checkpoint function in activated macrophages.

Fenghua Zhang, Md Yusuf Al-Amin, Sagar Utturkar, Rina Jiang, Gregory Cresswell, Rami Alfar, Ian Ophaug-Johansen, Gabriel Bachman, Madduri Srinivasarao, Richard Finnell and 3 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fenghua Zhang *Department of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, IN, United States.
Md Yusuf Al-Amin *Department of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, IN, United States.
Sagar UtturkarPurdue University Institute for Cancer Research, Purdue University, West Lafayette, IN, United States.
Rina JiangDepartment of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, IN, United States.
Gregory CresswellDepartment of Comparative Pathobiology, Purdue University, West Lafayette, IN, United States.
Rami AlfarDepartment of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, IN, United States.
Ian Ophaug-JohansenDepartment of Agricultural and Biological Engineering, Purdue University, West Lafayette, IN, United States.
Gabriel BachmanDepartment of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, IN, United States.
Madduri SrinivasaraoDepartment of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, IN, United States.
Richard FinnellCenter for Precision Environmental Health, Departments of Molecular and Human Genetics, Molecular and Cellular Biology and Medicine, Baylor College of Medicine, Houston, TX, United States.
Amaya Puig-KrögerUnidad de Immunometabolismo e Inflamación, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Timothy RatliffDepartment of Comparative Pathobiology, Purdue University, West Lafayette, IN, United States.
Philip S LowDepartment of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, IN, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monocytes and macrophages are sentinels of the immune system that distinguish themselves from other cells by expressing the beta isoform of the folate receptor (FRβ). Because FRβ does not bind folate until the monocyte/macrophage is exposed to immunosuppressive cytokines, the question naturally arose whether FRβ might also perform an immune-related function. To examine this matter, we compared the properties of wild type (WT) and FRβ knockout mice. We observe that FRβ knockout (KO) mice display autoimmune symptoms that can include alopecia, enlarged spleens, and dermatitis, despite having normal cellular folate levels. We further demonstrate that syngeneic tumors (TRAMP C2, MC38) grow much slower in FRβ KO mice than wildtype mice. Comparison of cells extracted from syngeneic tumors of KO mice further reveal that CD69+ T cells are increased while PD1+ T cells and PD-L1+ myeloid cells are decreased in KO tumors. More detailed comparison of the bone marrow-derived macrophages from KO and WT mice demonstrates that KO mice have upregulated pro-inflammatory genes and downregulated anti-inflammatory genes. Because blockade of FRβ with a monoclonal antibody or deletion of FRβ impairs direct macrophage suppression of T cell activation

Indexed as

Folate Receptor 2Macrophage ActivationMacrophagesAnimalsCell Line, TumorLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutT-LymphocytesFolate Receptor 2cancer immunotherapyfolate receptor beta (FRβ, Folr2)immune checkpointmacrophage polarizationmacrophagesMDSCs (myeloid-derived suppressor cells)tumor-associated macrophages (TAMs)tumor microenvironment

Identifiers

PMID41089695
PMCPMC12515634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.